SecurityTOO / Teekay Offshore Partners L.P. (Y8565J101)
Institutional Owners94 (22 N-Q Owners)
Institutional Shares319,312,299 (ex. N-Q)
Institutional Value$ 812,161,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Teekay Offshore Partners L.P. (NYSE:TOO) has 94 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 319,312,299 shares. Largest shareholders include Brookfield Asset Management Inc., FMR LLC / Fidelity, Magnetar Financial LLC, Luminus Management Llc, Eagle Global Advisors Llc, CI Global Investments Inc., First Manhattan Co, Weiss Multi-Strategy Advisers LLC, Evergreen Capital Management Llc, and Susquehanna International Group, Llp.

Teekay Offshore Partners L.P. (NYSE:TOO) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2017-11-28 N-Q Variable Insurance Products Fund (see advisory)
2018-02-02 13F-HR CI Global Investments Inc. 2,500,000 4,300,000 72.00 5,950 10,148 70.55
2018-02-14 13F-HR MORGAN STANLEY 206,682 395,702 91.45 492 934 89.84
2018-02-14 13F-HR BARCLAYS PLC 22,000 0 -100.00 52 0 -100.00
2017-10-30 N-Q John Hancock Bond Trust (see advisory)
2018-02-02 13F-HR Seacrest Wealth Management, Llc 5,000 12
2018-02-14 13F-HR Invesco Ltd. 0 386,971 0 913
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 10,076 0 -100.00 29 0 -100.00
2018-02-14 13F-HR PEAK6 Investments, L.P. Call 1,000 0 -100.00 2 0 -100.00
2017-11-06 13F-HR Spot Trading L.l.c. Call 11,000 0 -100.00 32 0 -100.00
2018-02-09 13F-HR HAP Trading, LLC Put 125,000 47
2017-12-28 N-Q Fidelity Devonshire Trust (see advisory)
2018-01-17 13F-HR Cutler Group LP Put 82,900 0 -100.00 4 0 -100.00
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 68 0 -100.00 0 0
2018-03-13 13F-HR Luzich Partners Llc 641,029 0 -100.00 1,526 0 -100.00
2018-02-09 13F-HR Stratos Wealth Partners, LTD. 11,850 17,925 51.27 28 42 50.00
2017-10-30 N-Q Oppenheimer Steelpath Mlp Funds Trust (see advisory)
2017-10-27 N-Q Fidelity Advisor Series I (see advisory)
2018-02-14 13F-HR KEY GROUP HOLDINGS (CAYMAN), LTD. 988,521 988,521 0.00 2,353 2,333 -0.85
2017-11-03 13F-HR Global X Management CO LLC 38,151 0 -100.00 109 0 -100.00
2018-02-14 13F-HR AVENIR CORP 126,608 0 -100.00 301 0 -100.00
2018-02-02 13F-HR Aquamarine Capital Management, LLC 1,000,000 2,360
2018-04-13 13F-HR NORTHWEST WEALTH MANAGEMENT, LLC 89 0
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 807,657 866,002 7.22 1,922 2,044 6.35
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 254 254 0.00 1 1 0.00
2018-02-14 13F-HR Park West Asset Management LLC 2,430,398 0 -100.00 5,784 0 -100.00
2018-02-14 13F-HR Advisor Group, Inc. 2,584 100 -96.13 6 0 -100.00
2018-02-14 13F-HR TWO SIGMA SECURITIES, LLC 15,376 36
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 2,432,200 0 -100.00 5,789 0 -100.00
2018-01-29 13F-HR EXANE DERIVATIVES 58 53 -8.62 138 125 -9.42
2017-12-28 N-Q Fidelity Puritan Trust (see advisory)
2018-03-01 N-Q Nuveen Investment Trust Iii (see advisory)
2018-01-24 13F-HR IFP Advisors, Inc 166 0 -100.00 0 0
2018-02-09 13F-HR CITADEL ADVISORS LLC Call 13,500 0 -100.00 32 0 -100.00
2018-02-14 13F-HR Natixis 25,000 25,000 0.00 60 65 8.33
2018-02-12 13F-HR CITIGROUP INC 0 157,653 0 372
2017-10-20 13F-HR Gilman Hill Asset Management, LLC 288,610 0 -100.00 828 0 -100.00
2018-02-12 13F-HR CITIGROUP INC Put 550,000 1,298
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 0 149,455 0 353
2017-11-06 13F-HR Spot Trading L.l.c. 2,580 8,585 232.75 7 20 185.71
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 69,512 42,809 -38.41 165 101 -38.79
2017-12-29 N-Q Arrow Etf Trust (see advisory)
2017-11-06 13F-HR Dalton Investments LLC 491,700 0 -100.00 1,411 0 -100.00
2018-02-14 13F-HR LUMINUS MANAGEMENT LLC 6,928,544 10,969,207 58.32 16,490 25,888 56.99
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 363 363 0.00 1 1 0.00
2018-01-17 13F-HR Cutler Group LP Call 100 0 -100.00 0 0
2017-10-30 N-Q Nuveen All Cap Energy Mlp Opportunities Fund (see advisory)
2018-02-28 N-Q Fidelity Destiny Portfolios (see advisory)
2018-02-14 13F-HR HITE Hedge Asset Management LLC 1,267,072 592,345 -53.25 3,016 1,398 -53.65
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 0 283,700 0 670
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 49,516 19,201 -61.22 118 45 -61.86
2018-02-14 13F-HR WOLVERINE TRADING, LLC Call 11,300 26,600 135.40 27 63 133.33
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 53,957 14,687 -72.78 129 35 -72.87
2018-02-12 13F-HR VAN ECK ASSOCIATES CORP 675,473 618,956 -8.37 1,608 1,461 -9.14
2017-11-29 N-Q Brookfield Investment Funds (see advisory)
2018-02-08 13F-HR BABSON CAPITAL MANAGEMENT LLC 87,987 87,987 0.00 209 208 -0.48
2017-11-15 13F-HR Neuberger Berman Group LLC 489,735 0 -100.00 1,406 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC 3,485 58 -98.34 8 0 -100.00
2017-11-01 13F-HR PARK CIRCLE Co 70,000 0 -100.00 201 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 77,900 78,200 0.39 185 185 0.00
2018-02-14 13F-HR UBS Group AG 467,171 401,191 -14.12 1,112 947 -14.84
2017-11-27 N-Q John Hancock Variable Insurance Trust (see advisory)
2017-11-15 13F-HR Janney Montgomery Scott LLC 164,549 0 -100.00 472 0 -100.00
2018-01-17 13F-HR Cutler Group LP 17,422 0 -100.00 41 0 -100.00
2018-02-14 13F-HR WOLVERINE TRADING, LLC 43,310 44,266 2.21 103 104 0.97
2017-10-30 N-Q John Hancock Sovereign Bond Fund (see advisory)
2018-02-14 13F-HR ROYAL BANK OF CANADA 18,758 13,758 -26.66 45 32 -28.89
2018-02-12 13F-HR OPPENHEIMER FUNDS INC 552,343 546,843 -1.00 1,315 1,290 -1.90
2018-02-12 13F-HR Stockman Asset Management 0 28,200 0 391
2018-02-09 13F-HR Bank of New York Mellon Corp 0 15,021 0 36
2017-11-29 N-Q Brookfield Real Assets Income Fund Inc. (see advisory)
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 3,000 0 -100.00 7 0 -100.00
2018-04-18 13F-HR Integral Derivatives, LLC 13,000 0 -100.00 31 0 -100.00
2018-02-12 13F-HR EAGLE GLOBAL ADVISORS LLC 9,253,835 4,412,357 -52.32 22,024 10,413 -52.72
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 88,600 57,900 -34.65 211 137 -35.07
2018-02-14 13F-HR PEAK6 Investments, L.P. 8,380 0 -100.00 20 0 -100.00
2018-02-14 13F-HR Walleye Trading LLC Put 20,000 47
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 605,584 1,035,172 70.94 1,441 2,443 69.54
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 366,021 365,544 -0.13 864 830 -3.94
2018-02-09 13F-HR Virtu Financial LLC 75,854 114,872 51.44 181 271 49.72
2018-02-07 13F-HR Benchmark Capital Advisors 81,500 70,500 -13.50 194 166 -14.43
2017-10-30 N-Q Investment Managers Series Trust (see advisory)
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 0 118,321 0 279
2018-02-14 13F-HR PEAK6 Investments, L.P. Put 9,500 0 -100.00 23 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 1,000 61,000 6,000.00 2 144 7,100.00
2018-01-17 13F-HR Creative Planning 24,795 0 -100.00 59 0 -100.00
2017-11-29 N-Q Brookfield Global Listed Infrastructure Income Fund Inc. (see advisory)
2018-02-14 13F-HR INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 117,095 0 -100.00 279 0 -100.00
2017-11-29 N-Q Wildermuth Endowment Strategy Fund (see advisory)
2018-02-09 13F-HR CITADEL ADVISORS LLC 55,945 92,389 65.14 133 218 63.91
2017-10-26 13F-HR Acrospire Investment Management LLC 2,869 0 -100.00 8 0 -100.00
2018-02-09 13F-HR Homrich & Berg 16,300 0 -100.00 39 0 -100.00
2017-12-21 N-Q American Pension Investors Trust (see advisory)
2018-02-14 13F-HR Atlantic Trust, LLC 10,580 0 -100.00 25 0 -100.00
2018-02-14 13F-HR THRIVENT FINANCIAL FOR LUTHERANS 455 0 -100.00 1 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 323,000 0 -100.00 769 0 -100.00
2018-01-29 13F-HR REILLY FINANCIAL ADVISORS, LLC 250 250 0.00 1 1 0.00
2018-02-13 13F-HR FIRST INTERSTATE BANK 1,000 2
2018-02-02 13F-HR Ballentine Partners, LLC 98,000 0 -100.00 233 0 -100.00
2018-02-08 13F-HR Global Financial Private Capital, LLC 25,017 25,017 0.00 60 59 -1.67
2018-02-15 13F-HR Bb&t Investment Services, Inc. 14 14 0.00 0 0
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 13,499 0 -100.00 32 0 -100.00
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. Put 437,500 537,500 22.86 1,041 1,269 21.90
2018-04-18 13F-HR Integral Derivatives, LLC Put 50,000 50,000 0.00 118 114 -3.39
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 10 113 1,030.00 0 0
2018-02-14 13F-HR HBK INVESTMENTS L P 0 14,300 0 34
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 48 10 -79.17 3 0 -100.00
2017-10-30 N-Q Fiduciary/claymore Mlp Opportunity Fund (see advisory)
2018-04-19 13F-HR Endurance Wealth Management, Inc. 9,100 6,900 -24.18 22 16 -27.27
2018-02-14 13F-HR EVERGREEN CAPITAL MANAGEMENT LLC 1,442,062 1,317,102 -8.67 3,432 3,108 -9.44
2018-04-04 13F-HR DAVENPORT & Co LLC 44,050 99,994
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 1,171,054 992,159 -15.28 2,787 2,341 -16.00
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 73,100 73,100 0.00 174 173 -0.57
2018-02-14 13F-HR Weiss Multi-Strategy Advisers LLC 1,341,251 1,341,251 0.00 3,192 3,165 -0.85
2018-02-12 13F-HR Arrow Investment Advisors, LLC 339,180 278,480 -17.90 807 657 -18.59
2018-01-22 13F-HR FIRST MANHATTAN CO 2,745,075 6,478
2018-02-12 13F-HR OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 10,964 10,964 0.00 26 26 0.00
2017-11-06 13F-HR Spot Trading L.l.c. Put 5,300 42,200 696.23 15 100 566.67
2018-02-14 13F-HR Magnetar Financial LLC 13,912,864 12,543,904 -9.84 33,113 29,604 -10.60
2017-10-30 N-Q Nuveen Energy Mlp Total Return Fund (see advisory)
2018-02-14 13F-HR Walleye Trading LLC 0 4,953 0 12
2018-02-08 13F-HR ADVISORY RESEARCH INC 8,949,514 13,795 -99.85 21,300 33 -99.85
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 19,900 0 -100.00 47 0 -100.00
2018-02-14 13F-HR BROWN BROTHERS HARRIMAN & CO 2,500 0 -100.00 6 0 -100.00
2018-03-05 13F-HR/A-2 BROOKFIELD ASSET MANAGEMENT INC. 244,000,000 243,999,999 -0.00 499,950 575,841 15.18
2017-11-13 13F-HR Evercore Wealth Management, LLC 5,500 0 -100.00 16 0 -100.00
2017-10-27 N-Q Vaneck Vectors Etf Trust (see advisory)
2018-02-14 13F-HR NORTHERN TRUST CORP 80,187 54,396 -32.16 191 128 -32.98
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 29,512 22,269 -24.54 70 53 -24.29
2018-02-20 13F-HR Pin Oak Investment Advisors Inc 162,400 383
2018-01-26 13F-HR ENTERPRISE FINANCIAL SERVICES CORP 1,200 1,200 0.00 3 3 0.00
2018-02-14 13F-HR RAYMOND JAMES & ASSOCIATES 76,052 89,420 17.58 181 211 16.57
2018-04-06 13F-HR Berson & Corrado Investment Advisors, LLC 111,758 107,296 -3.99 264 244 -7.58
2017-10-26 N-Q Global X Funds (see advisory)
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 744,500 1,091,800 46.65 1,772 2,577 45.43
2018-02-13 SC 13G/A FMR LLC / Fidelity 13,278,697 27,125,824 104.28
2018-02-02 13F-HR Barnett & Company, Inc. 1,600 550 -65.62 4 1 -75.00
2018-02-12 13F-HR Pinnacle Holdings, LLC 9,457 9,457 0.00 22,508 22,319 -0.84
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 1,600 1,600 0.00 4 4 0.00
2018-02-14 13F-HR DEUTSCHE BANK AG\ 125 18,841 14,972.80 0 44
2018-02-12 13F-HR RR Advisors, LLC 325,000 768

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( TOO / Teekay Offshore Partners L.P. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: Y8565J101